anemodeanin a has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; He, K; Huang, X; Jiang, J; Wang, K; Wang, T; Wang, Z; Yang, Z; Zhao, L; Zhao, W | 1 |
| Bai, S; Dong, Y; Hu, C; Lyu, J; Xia, H; Yu, X; Zhan, Y; Zhang, BY; Zhao, L | 1 |
2 other study(ies) available for anemodeanin a and Cancer of Prostate
| Article | Year |
|---|---|
A Pegylated Liposome Loaded with Raddeanin A for Prostate Cancer Therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Humans; Liposomes; Male; Mice; Polyethylene Glycols; Prostatic Neoplasms | 2023 |
Raddeanin A down-regulates androgen receptor and its splice variants in prostate cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Docetaxel; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Male; PC-3 Cells; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Receptors, Androgen; RNA Splicing; Saponins | 2019 |